Ayurvedic diagnosis of heart disease and effect of Pushkar ghan vati in patients of coronary artery disease

Panchnidanatmaka study and effect of Pushkar Ghana Vati in Patients of Hridroga W.S.R.to Coronary Artery Disease

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023813

Enrollment

Registered

2020-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery Health Condition 2: I25- Chronic ischemic heart disease

Interventions

Intervention1: Pushkar ghan vati: DOSE -500 mg tab thrice a day ANUPAN -water Mode of administration - oral Follow up - After 1 month Course

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic patients representing Coronary artery disease Hypertensive patients representing coronary artery disease

Exclusion criteria

Exclusion criteria: Pregnancy Infective pathology of heart like Rheumatic heart disease, subacute bacterial endocarditis, Pericarditis, endocarditis, Congenital heart disease,Tuberculosis, Coronary artery disease leading to left ventricular and right ventricular heart failure

Design outcomes

Primary

Measure	Time frame
Panchnidanatmaka study of Hridroga is a tool to evaluate the different level of coronary artery diseaseTimepoint: 180 days	—

Secondary

Measure	Time frame
Phushkar ghan vati is effective in Hridrog w.s.r. coronary artery diseaseTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Shalini Rai

All india institute of Ayurveda

vd.raishalini@gmail.com9389423843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026